BDNF and myeloid sarcoma: We identified BDNF variability in time, compared the values of MS patients with healthy controls, studied the effect of different treatments on BDNF and correlated BDNF with other variables, such as disease duration, relapses, brain MRI lesions and neurological disability tests.